MIRA INFORM REPORT

 

 

Report Date :

13.09.2013

 

IDENTIFICATION DETAILS

 

Name :

UNIMED TECHNOLOGIES LIMITED (w.e.f. 18.05.2010)

 

 

Formerly Known As :

MILMET PHARMA LIMITED (w.e.f. 10.07.2002)

EQUITY PHARMA LIMITED

 

 

Registered Office :

Baska, Ujeti Road, Ujeti Halol, District Panchmahal – 389 350, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

17.01.1997

 

 

Com. Reg. No.:

04-031523

 

 

Capital Investment / Paid-up Capital :

Rs.0.830 Million

 

 

CIN No.:

[Company Identification No.]

U24230GJ1997PLC031523

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BRDM01170B

 

 

PAN No.:

[Permanent Account No.]

AAACE4022B

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical Products, Drugs and Intermediates.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (29)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 312000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Exists

 

 

Comments :

Subject is an established company having moderate track record. There appears huge external borrowing taken by the company in 2012.

 

Liquidity position of the company is under threat.

 

However, company is performing well with regards to overall operation. Trade relations are fair. Business is active. Payment terms are slow but correct.

 

The company can be considered for business dealing with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

We are living in a world where volatility and uncertainty have become the New Normal. We saw a change of government in countries like Tunisia, Egypt, Libya and Vietnam. Once powerful countries in Europe are now fighting for bankruptcy. We have taken growth in the developing part of the world for granted but economic growth in China and India has begun to slow. Companies that were synonymous with their product categories just a few years ago are now no longer in existence. Kodak, the inventor of the digital camera had to wind up its operations, HMV, the British entertainment retailing company and Borders, once the second largest bookstore have shut down due to their inability to evolve their business models with the changing time. Readers’ Digest, Thomson Register are no more !

 

There is another megatrend happening. The World order is changing as economic power shifts from West to East. According to McKinsey study, it took Britain more than 100 years to double its economic output per person during its industrial revolution and the US later took more than 50 years to do the same. More than a century later, China and India have doubled their GDP per capital in 12 and 18 years respectively. By 2020, emerging Asia will become the world’s largest consuming block, overtaking North America.

 

The years after the outbreak of the global financial crisis, the world economy continues to remain fragile. The Indian economy demonstrated remarkable resilience in the initial years of the contagion but finally lost ground last year. GDP growth slowed down. Currency has been weakening. There is a marked deceleration in agriculture, industry and services. Dampening sentiment led to a cut-back in investment as well as private consumption expenditure.  Inflation remained at high levels fuelled by the pressure from the food and fuel sectors. The large fiscal and current account deficit s continued to cause grave concern. It is imperative that India regains its growth trajectory of 8-9 % sooner than later. This is crucially important given the need to create gainful livelihood opportunities for the millions living in poverty as also the large contingent of young people joining the job market every year.

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

LOCATIONS

 

Registered/ Factory Office :

Baska, Ujeti Road, Ujeti Halol, District Panchmahal – 389 350, Gujarat, India

Tel. No.:

91-2676-247232/ 247231

Fax No. :

91-2676-247232

E-Mail :

Sansh1020@yahoo.com

 

 

Branch Office :

F.P. 145, Ram Mandir Road, 1st Floor, Vile Parle (East), Mumbai – 400 057, Maharashtra, India

Tel. No.:

91-22-26115456/ 26123549

Fax No. :

91-22-26120421

 

 

DIRECTORS

 

AS ON 29.09.2012

 

Name :

Mr. Sanjay Sharma

Designation :

Whole-time Director

Address :

C-502, New Harvardgarden Co-operative Housing Society Limited, Greenwood complex, Ghodbunder Road, Thane (west), Thane – 400 607, Maharashtra, India

Date of Birth/Age :

10.02.1961

Date of Appointment :

29.06.2011

DIN No.:

03514943

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24230GJ1997PLC031523

UNIMED TECHNOLOGIES LIMITED.

Whole-time director

29-06-11

01-04-11

Active

NO

 

 

Name :

Mr. Kulvir Kadwadkar

Designation :

Director

Address :

Bhagwan Singh Colony, Building No.2, Block No.5, Senapati Bapat Marg, Mahim, Mumbai – 400 015, Maharashtra, India

Date of Birth/Age :

26.11.1960

Date of Appointment :

29.09.2009

DIN No.:

01576013

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U65999GJ1988PLC010304

UNIMED INVESTMENTS LIMITED

Director

31-12-02

31-12-02

14-08-10

Active

NO

2

U24230GJ1997PLC031523

UNIMED TECHNOLOGIES LIMITED.

Director

29-09-09

28-03-09

-

Active

NO

 

 

Name :

Mr. Kailash Multanmal Sankhlecha

Designation :

Director

Address :

414, Saffron Complex, Opposite Indian Air lines Office, Fatehgunj, Vadodara – 390 002, Gujarat, India

Date of Birth/Age :

13.08.1964

Date of Appointment :

29.09.2009

DIN No.:

01545371

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U65999GJ1988PLC010304

UNIMED INVESTMENTS LIMITED

Director

24-03-00

24-03-00

14-08-10

Active

NO

2

U24230GJ1997PLC031523

UNIMED TECHNOLOGIES LIMITED.

Director

29-09-09

25-04-09

-

Active

NO

 

 

Name :

Pragnesh Kumar Doshi

Designation :

Director

Address :

33, Upkar Society, Near Anand Balwadi, Ellora Park, Vadodara – 390 007, Gujarat, India

Date of Birth/Age :

29.12.1961

Date of Appointment :

28.12.2009

DIN No.:

01443468

Other directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U65999GJ1988PLC010304

UNIMED INVESTMENTS LIMITED

Director

24-03-00

24-03-00

14-08-10

Active

NO

2

U24230GJ1997PLC031523

UNIMED TECHNOLOGIES LIMITED.

Director

28-12-09

23-12-09

-

Active

NO

 

 

Name :

Mr. Ajaykumar Upadhyay

Designation :

Additional Director

Address :

108, Vitthalesh Avenue, New IPCL Road, Near Gorwa Workshop, Subhanpura, Vadodara – 390 000, Gujarat, India

Date of Birth/Age :

04.10.1966

Date of Appointment :

01.03.2013

DIN No.:

00065512

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U65999GJ1988PLC010304

UNIMED INVESTMENTS LIMITED

Whole-time director

31-12-02

31-12-02

01-05-07

Active

NO

2

U24230GJ1997PLC031523

UNIMED TECHNOLOGIES LIMITED.

Additional director

01-03-13

01-05-07

-

Active

NO

3

U90009GJ2010PLC062892

GREEN ECO DEVELOPMENT CENTRE LIMITED

Director

12-11-10

12-11-10

30-09-12

Active

NO

 

 

Name :

Mr. Sunil Roshanlal Ajmera

Designation :

Additional Director

Address :

404-B, Gardenia, Vasant Valley, Flimcity Road, Malad (East), Mumbai – 400 097, Maharashtra, India

Date of Birth/Age :

17.12.1970

Date of Appointment :

17.02.2012

DIN No :

00065545

 

 

MAJOR SHAREHOLDERS

 

AS ON 29.09.2012

 

Names of Shareholders

 

No. of Shares

 

 

 

Suraksha Realty Limited, India

 

78850

Minaxi Fiscal Services Private Limited, India

 

74700

Karad Chemicals and Allied Products Private Limited, India

 

74700

Sejraj Financial Services Limited, India

 

74700

Khyati Financial Services Private Limited, India

 

74700

Eklavya Securities Limited, India

 

74700

Suraksha Developers Limited, India

 

74700

Nisha Capital Services Limited, India

 

74700

Manmaya Developers Private Limited, India

 

74700

Khyati Realtors Private Limited, India

 

78850

Lakshdeep Investment and Finance Private Limited, India

 

74700

 

 

 

Total

 

830000

 

 

Equity Share Break up (Percentage of Total Equity)

 

AS ON 29.09.2012

 

Category

Percentage

Bodies corporate

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Products, Drugs and Intermediates.

 

 

Products :

Products/ services

ITC Code

Human Chorionic Gonadotrophin (FERTIGIN)

29371900

Menotrophin (GMH)

29371000

Sodium Hyaluronate (HYVISC)

29419090

 

 

PRODUCTION STATUS: (AS ON 31.03.2011)

 

PARTICULARS

(As certified by Management) (In Lacs)

2010-11

(Rs.)

Tablets/ Capsules/ Injection (In Lacs)

 

Licensed Capacity

NA

Install Capacity

1485.00

Actual Production (Incl. Loan License)

565.30

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

Not Available

 

 

Facilities :

SECURED LOANS

31.03.2012

Rs. In Millions

31.03.2011

Rs. In Millions

Short Term Borrowings

 

 

Repayable on Demand

 

 

Cash credit Facility

(Secured by lien on margin money deposits)

19.479

12.188

Total

19.479

12.188

 

Banking Relations :

--

 

 

Auditors :

 

Name :

K.C. Mehta and Company

Chartered Accountants

Address :

2nd Floor, Meghdhanush, Race Course, Vadodara – 390 007, Gujarat, India

PAN No.:

AABFK1558J

 

 

CAPITAL STRUCTURE

 

AS ON 29.09.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1000000

Equity Shares

Re.1/- each

Rs.1.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

830000

Equity Shares

Re.1/- each

Rs.0.830 Million

 

 

 

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

0.830

0.830

(b) Reserves & Surplus

 

77.276

61.965

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

78.106

62.795

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

0.000

0.000

(b) Deferred tax liabilities (Net)

 

7.614

5.515

(c) Other long term liabilities

 

1.516

1.516

(d) long-term provisions

 

2.031

1.705

Total Non-current Liabilities (3)

 

11.161

8.736

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

719.479

12.188

(b) Trade payables

 

784.374

545.833

(c) Other current liabilities

 

1794.538

277.275

(d) Short-term provisions

 

2.852

2.287

Total Current Liabilities (4)

 

3301.243

837.583

 

 

 

 

TOTAL

 

3390.510

909.114

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

192.267

87.471

(ii) Intangible Assets

 

3.752

4.837

(iii) Capital work-in-progress

 

114.834

105.013

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.076

0.076

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

29.610

31.966

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

340.539

229.363

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

2782.614

504.229

(c) Trade receivables

 

76.528

80.877

(d) Cash and cash equivalents

 

45.221

52.168

(e) Short-term loans and advances

 

145.527

42.403

(f) Other current assets

 

0.081

0.074

Total Current Assets

 

3049.971

679.751

 

 

 

 

TOTAL

 

3390.510

909.114

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

0.830

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

45.275

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

46.105

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

12.837

2] Unsecured Loans

 

 

0.000

TOTAL BORROWING

 

 

12.837

DEFERRED TAX LIABILITIES

 

 

4.013

 

 

 

 

TOTAL

 

 

62.955

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

80.181

Capital work-in-progress

 

 

27.270

 

 

 

 

INVESTMENT

 

 

0.070

DEFERRED TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

373.172

 

Sundry Debtors

 

 

26.022

 

Cash & Bank Balances

 

 

56.292

 

Other Current Assets

 

 

0.000

 

Loans & Advances

 

 

55.348

Total Current Assets

 

 

510.834

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 

537.635

 

Other Current Liabilities

 

 

15.175

 

Provisions

 

 

2.590

Total Current Liabilities

 

 

555.400

Net Current Assets

 

 

(44.566)

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

62.955

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

947.202

894.019

1092.974

 

 

Other Income

4.311

2.676

2.449

 

 

TOTAL                                     (A)

951.513

896.695

1095.423

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

299.948

288.324

 

 

Purchase of stock-in-trade

2599.650

451.187

 

 

 

Changes in Inventories of work-in-progress and stock-in-trade

(2267.609)

(103.771)

 

 

Employee benefit expenses

100.524

73.090

 

 

 

Other Expenses

187.229

158.313

 

 

 

TOTAL                                     (B)

919.812

867.143

1077.436

 

 

 

 

 

Less

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

31.701

29.552

17.987

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

0.159

0.269

0.356

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                (E)

31.542

29.283

17.631

 

 

 

 

 

Less/

DEPRECIATION/ AMORTISATION                     (F)

8.835

4.490

3.415

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX (E-F)                  (G)     

22.707

24.793

14.216

 

 

 

 

 

Less

TAX                                                                  (H)

7.395

8.104

5.166

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX (G-H)                    (I)

15.312

16.689

9.050

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

29.907

13.218

4.168

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

45.219

29.907

13.218

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export (FOB Basis)

274.163

240.149

78.853

 

TOTAL EARNINGS

274.163

240.149

78.853

 

 

 

 

 

 

Earnings Per Share (Rs.)

18.45

20.11

10.90

 

 

 

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

1.61

1.86

0.83

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

2.40

2.77

1.30

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

0.70

3.21

2.41

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.29

0.39

0.31

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

9.21

0.19

0.28

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.92

0.81

0.92

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

Yes

23]

Banking Details

No

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

LITIGATION DETAILS:

 

HIGH COURT OF GUJARAT

 

STAMP NUMBER No. 1995 of 2009


Status : PENDING

 

CCIN No : 001087200901995

 

 

Last Listing Date:

-

 

Coram

·         -

 

 

 

 

S.NO.

Name of the Petitioner

Advocate On Record

1

COMMISSIONER - CENTRAL EXCISE AND CUSTOMS VADODARA-II

MR GAURANG H BHATT for: null http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png1

 

S.NO.

Name of the Respondant

Advocate On Record

1

UNIMED TECHNOLOGIES LIMITED

 

 

 

Presented On

: 17/06/2009

Registered On

: 17/06/2009

Bench Category

: DIVISION BENCH

District

: VADODARA

Case Originated From

: THROUGH ADVOCATE

Listed

: 0 times

StageName

: FOR ADMISSION TAXATION MATTERS

 

 

 

 

Act

  • CENTRAL EXCISES AND SALT ACT, 1944

 

 

 

Office Details

 

S. No.

Filing Date

Document Name

Advocate Name

Court Fee on Document

Document Details

1

17/06/2009

CERTIFIED COPY

MR GAURANG H BHATT ADVOCATE
for PETITIONER(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png1

6

MR GAURANG H BHATT:1

2

17/06/2009

MEMO OF APPEAL/PETITION/SUIT

MR GAURANG H BHATT ADVOCATE
for PETITIONER(s) http://gujarathc-casestatus.nic.in/gujarathc/images/arrow1.png1

50

MR GAURANG H BHATT:1

 

 

UNSECURED LOANS:

 

Particulars

31.03.2012

Rs. In Millions

31.03.2011

Rs. In Millions

Short Term Borrowings

 

 

From Other Parties

700.000

0.000

Total

700.000

0.000

 

 

NOTE: No Charges Exist For the company.

 

 

NOTE: Registered office of the company has been shifted from 402, R K Centre, 4th Floor, Fatehgunj, Main Road, Baroda – 390 002, Gujarat, India to the present address w.e.f. 13.03.2009

 

 

FIXED ASSETS:

 

Tangible Assets:

·         Freehold Land

·         Building

·         Plant and Machinery

·         Equipments

·         Vehicles

·         Furniture and fixture

 

Intangible Assets:

·         Patents and Trademarks

 

 

 

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.67

UK Pound

1

Rs.100.71

Euro

1

Rs.84.72

 

 

INFORMATION DETAILS

 

Report Prepared by :

NKT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

2

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

29

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.